23 May 2013
Keywords: astellas, pharma, vaprisol, gains, fda, approval, subsidiary
Article | 09 January 2006
The US subsidiary of Japan's Astellas Pharma says that its drug Vaprisol (conivaptan hydrochloride injection) has been approved by
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 January 2006
22 May 2013
© 2013 thepharmaletter.com